Indomethacin (INC) Pharmacokinetics in Extremely Premature Infants who Receive Prophylactic (P) ICN in the First 24H of Life for Prevention of Patent Ductus Arteriosus (PDA) • 991 | Zendy

AI Assistant Blog Pricing

Indomethacin (INC) Pharmacokinetics in Extremely Premature Infants who Receive Prophylactic (P) ICN in the First 24H of Life for Prevention of Patent Ductus Arteriosus (PDA) • 991

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.